| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/10/2007 | US7241746 contains misoprostol, a tetracycline (doxycycline), an aminoglycoside (gentamicin), a fluoroquinoline (ciprofloxacin), a lincomycin (clindamycin), a macrolide (clarithromycin), an azalide (azithromycin), and an imidazole (metronidazole) |
| 07/10/2007 | US7241743 Sir2α-based therapeutic and prophylactic methods |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241618 A polynucleotide comprising a RNA polymerase promoter, able encoding a siRNA; treating cancer and genetic disorders; genetic engineering, inhibit gene expression of a target gene |
| 07/10/2007 | US7241581 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein |
| 07/10/2007 | US7241576 Applications of a novel cytokine, named THANK, for TNF homologue that activates apoptosis, NF- kappa B and c-jun N-terminal kinase. Such applications include using THANK inhibitors to inhibit the activation of NF-kappa B and to |
| 07/10/2007 | US7241571 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 07/10/2007 | US7241461 Compositions for alleviating inflammation and oxidative stress in a mammal |
| 07/10/2007 | US7241460 Strontium compound for treatment of sub-dermal soft tissue pain |
| 07/10/2007 | US7241445 Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 07/10/2007 | CA2421910C Xanthine phosphodiesterase v inhibitors |
| 07/10/2007 | CA2380072C Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/10/2007 | CA2283564C Pharmaceutical compositions having appetite suppressant activity |
| 07/10/2007 | CA2184461C A method for inhibiting an irregular binding of human lens cells |
| 07/06/2007 | CA2532283A1 Drug formulation for mouth or pharynx comprising local anesthetic |
| 07/05/2007 | WO2007076454A1 Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 07/05/2007 | WO2007075808A2 Methods for preventing and/or treating a cell proliferative disorder |
| 07/05/2007 | WO2007075673A1 Treatment regimen for n-myc, c-myc, and l-myc amplified and overexpressed tumors |
| 07/05/2007 | WO2007075555A2 Combination of an h3 antagonist/inverse agonist and an appetite suppressant |
| 07/05/2007 | WO2007075554A2 Combination of igfr inhibitor and anti-cancer agent |
| 07/05/2007 | WO2007075525A2 Combination of an iap-inhibitor and a taxane7 |
| 07/05/2007 | WO2007075120A1 Method for producing a stable aqueous solution of a product containing active substances and a product (variants) |
| 07/05/2007 | WO2007074916A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | WO2007074884A1 Therapeutic agent for diabetes |
| 07/05/2007 | WO2007074707A1 THERAPEUTIC AGENT FOR NEUROBLASTOMA TARGETING ARID3b |
| 07/05/2007 | WO2007074604A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance |
| 07/05/2007 | WO2007073782A1 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 07/05/2007 | WO2007073596A1 Degradable polymeric microsphere composition |
| 07/05/2007 | WO2007058392A9 Heterocyclic compound and medicinal application thereof |
| 07/05/2007 | WO2007028169A3 A method for cell implantation |
| 07/05/2007 | WO2007027560A3 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 07/05/2007 | WO2007017764A3 Substituted benzimidazole compounds with dual nos inhibitory activity and muopioid agonist activity |
| 07/05/2007 | WO2006125077A3 Non-natural chemokine receptor ligands and methods of use thereof |
| 07/05/2007 | WO2006045963A3 Composition of cosmetic or pharmacological application for stimulation of synthesis of collagen |
| 07/05/2007 | WO2004043226A3 Methods for predicting whether subjects with mild cognitive impairment (mci) will develop alzheimer's disease |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070155817 Indolylmaleimide derivatives |
| 07/05/2007 | US20070155814 Immunomodulatory compositions |
| 07/05/2007 | US20070155781 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase |
| 07/05/2007 | US20070155759 Using 1-acylpiperidine substance P antagonists; gastrointestinal disorders, analgesics, antiinflammatory agents, central nervous system disorders, rheumatic diseases |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155703 Pharmaceutically active compounds and methods of use thereof |
| 07/05/2007 | US20070155693 Inhibitor of cancer bone metastasis |
| 07/05/2007 | US20070155689 Methods of regulating growth and death of cancer cells |
| 07/05/2007 | US20070155679 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations |
| 07/05/2007 | US20070155673 Preferentiasl killing by contacting cell with 5-bromovinyl-2-deoxyuridine; anticancer agents |
| 07/05/2007 | US20070155670 Pyrrolidine Melanocortin-Specific Compounds |
| 07/05/2007 | US20070155664 Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| 07/05/2007 | US20070154933 Reagents and Methods for Identifying Gene Targets for Treating Cancer |
| 07/05/2007 | US20070154905 Modulators of the function of fas receptors and other proteins |
| 07/05/2007 | US20070154583 Treatment Of Inflammatory Bowel Disease |
| 07/05/2007 | US20070154483 Treatment with anti-vegf antibodies |
| 07/05/2007 | US20070154452 Therapeutic agent for pancreas cancer |
| 07/05/2007 | US20070154428 Thiazole derivative |
| 07/05/2007 | DE20122736U1 Beschichteter Ballonkatheter Coated balloon catheter |
| 07/05/2007 | DE102006013918A1 Verfahren zur Bräunung der Haut Process for the tanning of the skin |
| 07/05/2007 | DE102005061278A1 Sonnenbrandtuch Sunburn cloth |
| 07/05/2007 | CA2635777A1 Combination therapy for diabetes |
| 07/05/2007 | CA2635375A1 Synergistic effect between a cyanogenic system and another oxidative inducer for the treatment of tumours |
| 07/05/2007 | CA2635127A1 Method for the analysis of differential expression in colorectal cancer |
| 07/05/2007 | CA2634830A1 Degradable polymeric microsphere composition |
| 07/05/2007 | CA2634262A1 Antibodies against interleukin-22 binding protein and its uses |
| 07/05/2007 | CA2634235A1 Combination of an h3 antagonist/inverse agonist and an appetite suppressant |
| 07/05/2007 | CA2633356A1 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 07/05/2007 | CA2632508A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | CA2632256A1 Combination of an iap-inhibitor and a taxane7 |
| 07/04/2007 | EP1804064A1 Diagnostics and therapeutics for macular degeneration |
| 07/04/2007 | EP1804062A2 YKL-40 as a marker and prognostic indicator for cancers |
| 07/04/2007 | EP1803821A2 Methods for managing kinase inhibitor therapy |
| 07/04/2007 | EP1803810A1 Integrin antagonists |
| 07/04/2007 | EP1803729A1 1-( -d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof |
| 07/04/2007 | EP1803469A2 Medicaments for inhalation comprising betamimetics and an anticholinergic |
| 07/04/2007 | EP1803468A1 Agents for treatment of glaucomatours retinopathy and optic neuropathy |
| 07/04/2007 | EP1803467A1 Composite fine particles and process for producing the same |
| 07/04/2007 | EP1803462A2 Application of compounds containing petasites for treating diseased states |
| 07/04/2007 | EP1803458A1 Use of inorganic salts in the treatment of inflammation |
| 07/04/2007 | EP1803452A1 Ester derivative and pharmaceutical use thereof |
| 07/04/2007 | EP1802656A1 Tweak receptor |
| 07/04/2007 | EP1802292A2 Compositions and methods for inducing hair growth |
| 07/04/2007 | EP1626714B1 Diaryl ureas for diseases mediated by pdgfr |
| 07/04/2007 | EP1581484B1 Hydroxamic acid derivatives having anti-inflammatory action |
| 07/04/2007 | EP1523318A4 Treatment of human multiple myeloma by curcumin |
| 07/04/2007 | EP1494688A4 Use of topical compositions for the control of microbial diseases of the nail |
| 07/04/2007 | EP1478327A4 Method of reducing and treating uvb-induced immunosuppression |
| 07/04/2007 | EP1414405B1 Invert emulsion containing dhea |
| 07/04/2007 | EP1339349A4 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 07/04/2007 | EP1054594B1 Inotropic and diuretic effects of exendin and glp-1 |
| 07/04/2007 | EP1053023B1 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 07/04/2007 | EP0942750B1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 07/04/2007 | CN2917637Y Precharge preparation of antitumor agent |
| 07/04/2007 | CN1993106A Novel dermatological composition |
| 07/04/2007 | CN1990471A Mch antagonists and their use in the treatment of obesity |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1990057A An aerosol forming device for use in inhalation therapy |
| 07/04/2007 | CN1990045A Highly effective plaster for burn and scald and its preparation process |
| 07/04/2007 | CN1990044A Preparation and use of human body immunocompetent cell DCCIK anti-tumor cell preparation |
| 07/04/2007 | CN1990042A SARS coronary virus resistant cell vaccine and its uses |
| 07/04/2007 | CN1989968A Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |